The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes

被引:109
作者
Abdul-Ghani, Muhammad A. [1 ]
Lyssenko, Valeriya [2 ,3 ]
Tuomi, Tiinamaija [2 ,3 ]
DeFronzo, Ralph A. [1 ]
Groop, Leif [2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA
[2] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden
[3] Lund Univ, Ctr Diabet, Malmo, Sweden
基金
瑞典研究理事会;
关键词
shape of glucose tolerance curve; prediction of diabetes; OGTT; IMPAIRED FASTING GLUCOSE; BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; TOLERANCE; PATHOGENESIS; SECRETION; HISTORY; MUSCLE; LIVER;
D O I
10.1002/dmrr.1084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of the study is to assess the relationship between the shape of plasma glucose concentration during the OGTT and future risk for T2DM. Methods 2445 non-diabetic subjects from the Botnia study received an OGTT at baseline and after 7-8 years of follow-up. Results NGT and IFG subjects who returned their plasma glucose concentration following an ingested glucose load below FPG within 60 min had increased insulin sensitivity, greater insulin secretion and lower risk for future T2DM compared to NGT and IFG subjects whose post-load plasma glucose concentration required 120 min or longer to return their plasma glucose level to FPG level. IGT subjects who had a lower plasma glucose concentration at 1-h compared to 2-h during oGrr had greater insulin sensitivity, better beta cell function and lower risk for future T2DM. Conclusions These data suggest that the shape of glucose curve can be utilized to assess future risk for T2DM. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 23 条
  • [1] Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
    Abdul-Ghani, MA
    Tripathy, D
    DeFronzo, RA
    [J]. DIABETES CARE, 2006, 29 (05) : 1130 - 1139
  • [2] Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance - Results from the veterans administration genetic epidemiology study
    Abdul-Ghani, MA
    Jenkinson, CP
    Richardson, DK
    Tripathy, D
    DeFronzo, RA
    [J]. DIABETES, 2006, 55 (05) : 1430 - 1435
  • [3] What is the best predictor of future type 2 diabetes?
    Abdul-Ghani, Muhammad A.
    Williams, Ken
    DeFronzo, Ralph A.
    Stern, Michael
    [J]. DIABETES CARE, 2007, 30 (06) : 1544 - 1548
  • [4] Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test
    Abdul-Ghani, Muhammad A.
    Matsuda, Masafumi
    Balas, Bogdan
    DeFronzo, Ralph A.
    [J]. DIABETES CARE, 2007, 30 (01) : 89 - 94
  • [5] Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose
    Abdul-Ghani, Muhammad A.
    Williams, Ken
    DeFronzo, Ralph
    Stern, Michael
    [J]. DIABETES CARE, 2006, 29 (07) : 1613 - 1618
  • [6] ABDULGHANI MA, 2008, EUR J CLIN IN PRESS
  • [7] The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes
    Bergman, RN
    Finegood, DT
    Kahn, SE
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 : 35 - 45
  • [8] Reduced early insulin secretion in the etiology of type 2 diabetes mellitus in Pima Indians
    Bogardus, C
    Tataranni, PA
    [J]. DIABETES, 2002, 51 : S262 - S264
  • [9] The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance - Poor agreement in the Hoorn study
    De Vegt, F
    Dekker, JM
    Stehouwer, CDA
    Nijpels, G
    Bouter, LM
    Heine, R
    [J]. DIABETES CARE, 1998, 21 (10) : 1686 - 1690
  • [10] THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM
    DEFRONZO, RA
    [J]. DIABETES, 1988, 37 (06) : 667 - 687